Skip to main content
main-content

Expert opinion

Neuer Inhalt Free registration

Gain full access to the latest clinical content available from Springer Nature


Concise and thought-provoking commentary, opinion and analysis from diabetes practitioners and researchers.


Compassion fatigue in diabetes care professionals

Compassion

Awareness and education about compassion fatigue can help to limit its incidence and severity. Sanjay Kalra outlines strategies to identify and manage the emotional exhaustion that often affects diabetes caregivers.

Does setting treatment targets risk the overtreatment of type 2 diabetes in older patients?

Elderly overtreatment

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

Diabetes in special situations: Insulin in diabetic foot ulcers

Foot care

Formal guidance addressing the optimal use of insulin therapy in diabetic foot ulcer patients is lacking. Editorial Board member Sanjay Kalra and Banshi Saboo present their pragmatic approach to treatment.

Sodium-glucose cotransporter-2 inhibitors for type 1 diabetes: Ready for prime time?

Traffic light

Editorial board member John Wilding casts a critical eye over the positive buzz surrounding the potential uses of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes treatment.

Physical activity for health, weight loss, and diabetes prevention and treatment: What should be recommended?

Physical activity

Editorial Board member John Wilding highlights the current evidence for the benefits of physical activity across various domains of type 2 diabetes care and prevention, presenting his view of what should be recommended.

What is new in the 2018 American Diabetes Association Standards of Medical Care in Diabetes?

Diabetes Care cover

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2018's ADA Standards of Care update. 

A pragmatic and practical guide to U500 regular insulin usage

Insulin injection (Fotolia_30098449_Subsc)

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

Real-world evidence: Complementing clinical trials in type 2 diabetes

John Wilding

Editorial Board member John Wilding examines what real-world data means to today’s clinicians and presents his vision for the future of this type of evidence.

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Heart and ECG_Fotolia_287046_Subscription_XL

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

Gestational diabetes mellitus: Opportunity, not despair

Diabetes and pregnancy_AdobeStock_158940533

Should gestational diabetes mellitus be viewed as an opportunity, or an inequality, and should it be a cause for dynamism or despair? Sanjay Kalra and Ankia Coetzee present their perspective on gestational diabetes mellitus.

Longer-acting basal insulin analogs: What, how, why, when, and who?

Insulin pen

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U-300 insulin glargine and insulin degludec.

Diabetes in special situations: Glucagon-like peptide-1 receptor agonist use in acute myocardial infarction

ECG

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.

Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

eye_104203257

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Type 2 diabetes can be prevented in your patients

Prevent diabetes

Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.

Is it harder to treat diabetes today?

New Content Item

Treating type 2 diabetes has become so complicated. Why is this so? Editorial Board member Jay Shubrook discusses the reasons and suggests ways to make diabetes treatment less overwhelming.

Metformin: What is new with this old medication?

medication capsule

With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded.

Clinical implications of cardiovascular outcomes trials in type 2 diabetes

Artery Disease

What do the results of CVOTs mean for practicing clinicians? Medicine Matters contributor, Carol Wysham reviews the latest evidence and guidelines for reducing CV risk in patients with type 2 diabetes.

Progress in diabetes care: looking back at 2016

2017

As 2016 draws to a close, our editorial board members reflect on the key advances in understanding and treating diabetes over the past year, and give their thoughts on the research to watch out for in 2017.

What is new in the 2017 American Diabetes Association Standards of Care?

Guidelines

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2017's ADA Standards of Care update. 

Choosing an insulin delivery device

Insulin pen

A process of shared and informed decision-making, facilitated by demonstration, helps ensure that the right delivery device is chosen and prescribed for persons who require insulin.

02-21-2018 | Primary care | Editorial | Article

Compassion fatigue in diabetes care professionals

Awareness and education about compassion fatigue can help to limit its incidence and severity. Sanjay Kalra outlines strategies to identify and manage the emotional exhaustion that often affects diabetes caregivers.

Author:
Sanjay Kalra

02-13-2018 | Older adults | Editorial | Article

Does setting treatment targets risk the overtreatment of type 2 diabetes in older patients?

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

Authors:
Amar Puttanna, John Wilding

01-29-2018 | Diabetic foot ulcers | Editorial | Article

Diabetes in special situations: Insulin in diabetic foot ulcers

Formal guidance addressing the optimal use of insulin therapy in diabetic foot ulcer patients is lacking. Editorial Board member Sanjay Kalra and Banshi Saboo present their pragmatic approach to treatment.

Authors:
Sanjay Kalra, Banshi Saboo

01-16-2018 | Type 1 diabetes | Editorial | Article

Sodium-glucose cotransporter-2 inhibitors for type 1 diabetes: Ready for prime time?

Editorial board member John Wilding casts a critical eye over the positive buzz surrounding the potential uses of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes treatment.

Author:
John Wilding

01-03-2018 | Physical activity | Editorial | Article

Physical activity for health, weight loss, and diabetes prevention and treatment: What should be recommended?

Editorial Board member John Wilding highlights the current evidence for the benefits of physical activity across various domains of type 2 diabetes care and prevention, presenting his view of what should be recommended.

Author:
John Wilding

12-14-2017 | Guidelines | Editorial | Article

What is new in the 2018 American Diabetes Association Standards of Medical Care in Diabetes?

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2018's ADA Standards of Care update. 

Author:
Jay Shubrook

12-05-2017 | Insulin | Editorial | Article

A pragmatic and practical guide to U500 regular insulin usage

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

Author:
Sanjay Kalra

11-28-2017 | Type 2 diabetes | Editorial | Article

Real-world evidence: Complementing clinical trials in type 2 diabetes

Editorial Board member John Wilding examines what real-world data means to today’s clinicians and presents his vision for the future of this type of evidence.

Author:
John Wilding

11-22-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

Author:
Sanjay Kalra

11-13-2017 | Gestational diabetes | Editorial | Article

Gestational diabetes mellitus: Opportunity, not despair

Should gestational diabetes mellitus be viewed as an opportunity, or an inequality, and should it be a cause for dynamism or despair? Sanjay Kalra and Ankia Coetzee present their perspective on gestational diabetes mellitus.

Authors:
Sanjay Kalra, Ankia Coetzee

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John Wilding

New Content Item Meet our Advisory Board

image credits